{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:45:59Z","timestamp":1778125559293,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"John Iazzetta and Katrina Hatzifilalithis"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jad.2018.07.073","type":"journal-article","created":{"date-parts":[[2018,7,29]],"date-time":"2018-07-29T00:15:45Z","timestamp":1532823345000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting"],"prefix":"10.1016","volume":"241","author":[{"given":"Mark","family":"Sinyor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Belo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Orser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Mah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Carlos","family":"Zarate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saulo","family":"Castel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayal","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.07.073_bib0001","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"Aan Het Rot","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0002","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","article-title":"Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety","volume":"58","author":"Ballard","year":"2014","journal-title":"J Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.07.073_bib0003","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2017.03.010","article-title":"Ketamine as a rapid-acting agent for suicidal ideation: a meta-analysis","volume":"77","author":"Bartoli","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.jad.2018.07.073_bib0004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.jad.2018.07.073_bib0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.aap.2005.03.004","article-title":"Suicide prevention through means restriction: assessing the risk of substitution. A critical review and synthesis","volume":"37","author":"Daigle","year":"2005","journal-title":"Accid. Anal. Prev."},{"key":"10.1016\/j.jad.2018.07.073_bib0006","first-page":"28","article-title":"The clinical global impressions scale","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.jad.2018.07.073_bib0007","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"DiazGranados","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0008","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.18632\/oncotarget.13743","article-title":"Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial","volume":"8","author":"Fan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jad.2018.07.073_bib0009","first-page":"30351","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","volume":"1064-7481","author":"George","year":"2017","journal-title":"Am. J. Geriatr. Psychiatry S."},{"key":"10.1016\/j.jad.2018.07.073_bib0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12991-015-0068-9","article-title":"The role of cognitive dysfunction in the symptoms and remission from depression","volume":"14","author":"Gonda","year":"2015","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0011","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bdi.12487","article-title":"Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial","volume":"19","author":"Grunebaum","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2018.07.073_bib0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0013","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single I.V. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2018.07.073_bib0014","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.pnpbp.2011.03.019","article-title":"Rapid decrease in depressive symptoms with an N-methyl-d-asparate antagonist in ECT-resistant major depression","volume":"35","author":"Ibrahim","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0015","doi-asserted-by":"crossref","first-page":"e719","DOI":"10.4088\/JCP.15m10056","article-title":"Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study","volume":"77","author":"Ionescu","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2045125316675578","article-title":"Use of repeated intravenous ketamine therapy in treatment-resistant bipolar depression with suicidal behaviour: a case report from Spain","volume":"7","author":"L\u00f3pez-D\u00edaz","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2018.07.073_bib0017","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMra050730","article-title":"The medical management of depression","volume":"353","author":"Mann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2018.07.073_bib0018","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.294.16.2064","article-title":"Suicide prevention strategies: a systematic review","volume":"294","author":"Mann","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2018.07.073_bib0019","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11599770-000000000-00000","article-title":"Ketamine for treatment-resistant unipolar depression: current evidence","volume":"26","author":"Mathew","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2018.07.073_bib0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0021","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0022","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0023","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2018.07.073_bib0024","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia- suicide severity rating scale (C-SSRS): initial validity and internal consistency findings from three multi-site studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0026","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"American Psychiatric Association (APA) council of research task force on novel biomarkers and treatments. A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0027","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0028","series-title":"The Sheehan Disability Scales. In the Anxiety Disease and How to Overcome it","first-page":"151","author":"Sheehan","year":"1983"},{"key":"10.1016\/j.jad.2018.07.073_bib0029","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1176\/appi.ajp.2016.16010037","article-title":"A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression","volume":"173","author":"Singh","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2215-0366(17)30102-5","article-title":"Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight","volume":"4","author":"Singh","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0031","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1038\/npp.2017.94","article-title":"Dose-related effects of adjunctive ketamine in Taiwanese patients with treatment-resistant depression","volume":"42","author":"Su","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.07.073_bib0032","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jad.2018.07.073_bib0033","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/npp.2011.306","article-title":"Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review","volume":"37","author":"Undurraga","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.07.073_bib0034","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jad.2016.09.008","article-title":"Continuation phase intravenous ketamine in adults with treatment-resistant depression","volume":"206","author":"Vande Voort","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.jad.2018.07.073_bib0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/PRA.0000000000000282","article-title":"Ketamine use for suicidal ideation in the general hospital: case report and short review","volume":"24","author":"Vulser","year":"2018","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jad.2018.07.073_bib0036","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis","author":"Wilkinson","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0037","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2215-0366(16)30030-X","article-title":"Suicide prevention strategies revisited: 10-year systematic review","volume":"3","author":"Zalsman","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0038","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.07.073_bib0039","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-asparate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718307407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032718307407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:19:41Z","timestamp":1759022381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032718307407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S0165032718307407"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.073","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine augmentation for major depressive disorder and suicidal ideation: Preliminary experience in an inpatient psychiatry setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}